These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Prognostic value of U2AF1 mutant in patients with de novo myelodysplastic syndromes: a meta-analysis. Wang H; Zhang N; Wu X; Zheng X; Ling Y; Gong Y Ann Hematol; 2019 Dec; 98(12):2629-2639. PubMed ID: 31754743 [TBL] [Abstract][Full Text] [Related]
12. U2AF35(S34F) Promotes Transformation by Directing Aberrant ATG7 Pre-mRNA 3' End Formation. Park SM; Ou J; Chamberlain L; Simone TM; Yang H; Virbasius CM; Ali AM; Zhu LJ; Mukherjee S; Raza A; Green MR Mol Cell; 2016 May; 62(4):479-90. PubMed ID: 27184077 [TBL] [Abstract][Full Text] [Related]
13. The splicing factor U2AF1 contributes to cancer progression through a noncanonical role in translation regulation. Palangat M; Anastasakis DG; Fei DL; Lindblad KE; Bradley R; Hourigan CS; Hafner M; Larson DR Genes Dev; 2019 May; 33(9-10):482-497. PubMed ID: 30842218 [TBL] [Abstract][Full Text] [Related]
15. Differential U2AF1 mutation sites, burden and co-mutation genes can predict prognosis in patients with myelodysplastic syndrome. Wang H; Guo Y; Dong Z; Li T; Xie X; Wan D; Jiang Z; Yu J; Guo R Sci Rep; 2020 Oct; 10(1):18622. PubMed ID: 33122737 [TBL] [Abstract][Full Text] [Related]
16. U2AF1 pathogenic variants in myeloid neoplasms and precursor states: distribution of co-mutations and prognostic heterogeneity. Badar T; Vanegas YAM; Nanaa A; Foran JM; Al-Kali A; Mangaonkar A; Murthy H; Alkhateeb HB; Viswanatha D; He R; Shah M; Yi CA; Litzow MR; Gangat N; Tefferi A; Patnaik MM Blood Cancer J; 2023 Sep; 13(1):149. PubMed ID: 37735430 [TBL] [Abstract][Full Text] [Related]
17. U2AF1 mutations in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome. Qian J; Yao DM; Lin J; Qian W; Wang CZ; Chai HY; Yang J; Li Y; Deng ZQ; Ma JC; Chen XX PLoS One; 2012; 7(9):e45760. PubMed ID: 23029227 [TBL] [Abstract][Full Text] [Related]
19. U2AF1 mutation connects DNA damage to the alternative splicing of RAD51 in lung adenocarcinomas. Chen C; Zhou P; Zhang Z; Liu Y Clin Exp Pharmacol Physiol; 2022 Jul; 49(7):740-747. PubMed ID: 35434831 [TBL] [Abstract][Full Text] [Related]
20. The RNA recognition motif of NIFK is required for rRNA maturation during cell cycle progression. Pan WA; Tsai HY; Wang SC; Hsiao M; Wu PY; Tsai MD RNA Biol; 2015; 12(3):255-67. PubMed ID: 25826659 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]